Publikationen von E. H. van der Horst

Reschke, M.; Mihic-Probst, D.; van der Horst, E. H.; Knyazev, P.; Wild, P. J.; Hutterer, M.; Meyer, S.; Dummer, R.; Moch, H.; Ullrich, A.: HER3 is a determinant for poor prognosis in melanoma. Clinical Cancer Research 14 (16), S. 5188 - 5197 (2008)

van der Horst, E. H.; Murgia, M.; Treder, M.; Ullrich, A.: Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies. International Journal of Cancer 115 (4), S. 519 - 527 (2005)

van der Horst, E. H.; Weber, I.; Ullrich, A.: Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: Novel heregulin/HER3-stimulated signaling pathway in glioma. International Journal of Cancer 113 (5), S. 689 - 698 (2005)

van der Horst, E. H.; Leupold, J. H.; Schubbert, R.; Ullrich, A.; Allgayer, H.: TaqMan((R))-based quantification of invasive cells in the chick embryo metastasis assay. BioTechniques 37 (6), S. 940 - 946 (2004)

Htun van der Horst, E.: The role of ErbB3/HER3 in gliomas and breast cancer: Molecular mechanisms and potential role a therapeutic target. Dissertation, Ludwig-Maximilians-Universität, München (2002)

Htun van der Horst, E.: The role of ErbB3/HER3 in gliomas and breast cancer: Molecular mechanisms and potential role as therapeutic target. Dissertation, Ludwig-Maximilians-Universität, München (2002)